Tong Ren Tang Technologies Schedules Board Meeting to Discuss Financial Results and Dividend

Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an update.

Tong Ren Tang Technologies Co. Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss several key financial and operational matters. The agenda includes approving the audited consolidated results for the year ending December 31, 2024, considering the recommendation of a final dividend, and potentially closing the register of members, which could have implications for shareholders and market positioning.

More about Tong Ren Tang Technologies Co

Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine products, focusing on both domestic and international markets.

YTD Price Performance: -5.85%

Average Trading Volume: 800

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $791.2M

See more insights into 1666 stock on TipRanks’ Stock Analysis page.